SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-176586
Filing Date
2024-07-09
Accepted
2024-07-09 08:36:57
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d854372ddefa14a.htm DEFA14A 11177
2 GRAPHIC g854372g34g34.jpg GRAPHIC 205882
3 GRAPHIC g854372g35g35.jpg GRAPHIC 161163
  Complete submission text file 0001193125-24-176586.txt   517952
Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Aileron Therapeutics, Inc. (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 134196017 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38130 | Film No.: 241106404
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)